Related Experiment Video

Updated: Jul 11, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment,

G Wennergren1, S Kristjánsson, I L Strannegård

  • 1Department of Pediatrics, University of Göteborg, Ostra Hospital, Sweden.

The Journal of Allergy and Clinical Immunology
|March 1, 1996
PubMed

Insights

Childhood asthma hospitalizations decreased significantly due to inhaled steroid treatment. This anti-inflammatory approach proved highly effective and cost-efficient for pediatric asthma management.

Area of Science:

  • Pediatric Pulmonology
  • Public Health
  • Pharmacotherapy

Background:

  • Asthma prevalence in Swedish children doubled over 15 years.
  • Inhaled steroid anti-inflammatory treatment increased concurrently since 1985.

Purpose of the Study:

  • To evaluate the impact of increased inhaled steroid use on pediatric asthma hospitalizations.
  • To analyze trends in hospital days and admissions for childhood asthma.

Main Methods:

  • Population-based study in Göteborg, Sweden (0.5 million inhabitants).
  • Data collected on hospital days, admissions, and individual patients for acute asthma (1985-1993).
  • Centralized inpatient care at a single children's hospital; consistent hospitalization policies.

Main Results:

  • Significant decrease in hospital days (to <1/3) and admissions (by 45%) for children aged 2-18 years.
  • Most pronounced reduction in older children (>5 years): hospital days reduced to 1/5, admissions halved.
  • Decreasing trend in hospital days observed in 2-5 year olds; no significant trend in individual patient admissions.

Conclusions:

  • Inhaled steroids are the primary driver for reduced pediatric asthma hospitalizations (ages 2-18).
  • Parent/patient education may be a contributing factor.
  • Anti-inflammatory treatment with inhaled steroids is a cost-effective strategy for pediatric asthma.
Abstract

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...